首页> 美国卫生研究院文献>Arthroscopy Techniques >Cartilage Repair in the Knee Using Umbilical Cord Whartons Jelly–Derived Mesenchymal Stem Cells Embedded Onto Collagen Scaffolding and Implanted Under Dry Arthroscopy
【2h】

Cartilage Repair in the Knee Using Umbilical Cord Whartons Jelly–Derived Mesenchymal Stem Cells Embedded Onto Collagen Scaffolding and Implanted Under Dry Arthroscopy

机译:使用脐带沃顿氏胶制成的间充质干细胞植入胶原蛋白支架并在干式关节镜下植入修复膝关节软骨

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell-based cartilage repair procedures are becoming more widely available and have shown promising potential to treat a wide range of cartilage lesion types and sizes, particularly in the knee joint. More recently, techniques have evolved from 2-step techniques that use autologous chondrocyte expansion to 1-step techniques that make use of mesenchymal stem cells (MSCs) embedded onto biocompatible scaffolding. Our 1-step technique has been further developed to provide cell-based cartilage repair using MSCs that have the potential to be used in an off-the-shelf manner, without the need for autologous tissue harvest. Precursor MSCs can be isolated in abundance from the Wharton's jelly of umbilical cord tissue. These cells have been shown to have the desired capacity for proliferation, differentiation, and release of trophic factors that make them an excellent candidate for use in the clinical setting to provide cell-based restoration of hyaline-like cartilage. Although allogeneic in nature, these cells stimulate little or no host immune response and can be stored for long periods while maintaining viability. We present a technique of cartilage repair in the knee using Wharton's jelly–derived MSCs embedded onto scaffolding and implanted in a minimally invasive fashion using dry arthroscopy.
机译:基于细胞的软骨修复程序正变得越来越广泛,并且已显示出有望治疗各种软骨病变类型和大小,特别是在膝关节中的潜力。最近,技术已从使用自体软骨细胞扩增的两步技术演变为利用嵌入生物相容性支架中的间充质干细胞(MSC)的一步技术。我们的1步技术已得到进一步发展,可使用MSC提供基于细胞的软骨修复,而该MSC可以以现成的方式使用,而无需自体组织收获。可以从沃顿氏脐带组织的果冻中大量分离前体MSC。这些细胞已显示出具有所需的营养因子增殖,分化和释放能力,这使其成为临床上用于提供基于细胞的透明质样软骨修复的优秀候选者。尽管本质上是同种异体,但这些细胞几乎不刺激宿主免疫反应,甚至不刺激宿主免疫反应,可以长期保存,同时保持活力。我们提出了一种使用沃顿氏胶冻源性MSC植入膝盖支架并通过干式关节镜以微创方式植入膝盖的软骨修复技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号